- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapy for Fragile X Syndrome: Progress to Date
Authors
Keywords
Attention Deficit Hyperactivity Disorder, Memantine, Attention Deficit Hyperactivity Disorder Symptom, Social Responsiveness Scale, Acamprosate
Journal
DRUGS
Volume 76, Issue 4, Pages 431-445
Publisher
Springer Nature
Online
2016-02-08
DOI
10.1007/s40265-016-0542-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence, Nature, and Correlates of Sleep Problems Among Children with Fragile X Syndrome Based on a Large Scale Parent Survey
- (2017) Rebecca Kronk et al. SLEEP
- Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain
- (2015) Shervin Gholizadeh et al. BRAIN RESEARCH
- The GABAAreceptor is an FMRP target with therapeutic potential in fragile X syndrome
- (2015) Sien Braat et al. CELL CYCLE
- Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of theFmr1Knockout Mouse Model of Fragile X Syndrome
- (2015) Henry G. S. Martin et al. CEREBRAL CORTEX
- NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
- (2015) Robert M. J. Deacon et al. NEUROMOLECULAR MEDICINE
- Selective Role of the Catalytic PI3K Subunit p110β in Impaired Higher Order Cognition in Fragile X Syndrome
- (2015) Christina Gross et al. Cell Reports
- Increased Expression of the PI3K Enhancer PIKE Mediates Deficits in Synaptic Plasticity and Behavior in Fragile X Syndrome
- (2015) Christina Gross et al. Cell Reports
- Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open-label study
- (2014) Artuela Çaku et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Cholesterol levels in Fragile X syndrome
- (2014) Elizabeth Berry-Kravis et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Analysis ofFmr1Deletion in a Subpopulation of Post-Mitotic Neurons in Mouse Cortex and Hippocampus
- (2014) Anahita Amiri et al. Autism Research
- Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs
- (2014) Daman Kumari et al. HUMAN MUTATION
- Quantitative Phosphoproteomics of Murine Fmr1-KO Cell Lines Provides New Insights into FMRP-Dependent Signal Transduction Mechanisms
- (2014) Katarina Matic et al. JOURNAL OF PROTEOME RESEARCH
- A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
- (2014) Alexander Kolevzon et al. Molecular Autism
- Clinical and molecular implications of mosaicism in FMR1 full mutations
- (2014) Dalyir Pretto et al. Frontiers in Genetics
- Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
- (2013) Aimee V. Franklin et al. BIOLOGICAL PSYCHIATRY
- Outcome Measures for Clinical Trials in Fragile X Syndrome
- (2013) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome
- (2013) Mary Jacena S. Leigh et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Electrocortical changes associated with minocycline treatment in fragile X syndrome
- (2013) Andrea Schneider et al. JOURNAL OF PSYCHOPHARMACOLOGY
- From FMRP Function to Potential Therapies for Fragile X Syndrome
- (2013) Ferzin Sethna et al. NEUROCHEMICAL RESEARCH
- Mechanism of Action for NNZ-2566 Anti-inflammatory Effects Following PBBI Involves Upregulation of Immunomodulator ATF3
- (2013) Casandra M. Cartagena et al. NEUROMOLECULAR MEDICINE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome
- (2013) Craig A. Erickson et al. PSYCHOPHARMACOLOGY
- Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice
- (2013) Giulia Curia et al. Frontiers in Cellular Neuroscience
- Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
- (2013) Ozlem Bozdagi et al. Molecular Autism
- Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model
- (2012) Inge Heulens et al. BEHAVIOURAL BRAIN RESEARCH
- RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome
- (2012) Yujing Li et al. BRAIN RESEARCH
- Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
- (2012) Luigi Boccuto et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Effectiveness and Safety of Donepezil in Boys With Fragile X Syndrome
- (2012) Jitendra Kumar Sahu et al. JOURNAL OF CHILD NEUROLOGY
- Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome
- (2012) Xinglong Wang et al. JOURNAL OF NEUROCHEMISTRY
- Trajectories of Early Brain Volume Development in Fragile X Syndrome and Autism
- (2012) Heather Cody Hazlett et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
- (2012) Aditi Bhattacharya et al. NEURON
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- The trouble with spines in fragile X syndrome: density, maturity and plasticity
- (2012) C.X. He et al. NEUROSCIENCE
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
- (2012) E. M. Berry-Kravis et al. Science Translational Medicine
- Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
- (2011) Michael R. Santoro et al. Annual Review of Pathology-Mechanisms of Disease
- Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
- (2011) O.S. Descamps et al. ATHEROSCLEROSIS
- Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome
- (2011) Alexia M. Thomas et al. BEHAVIOURAL BRAIN RESEARCH
- What Can We Learn about Autism from Studying Fragile X Syndrome?
- (2011) Dejan B. Budimirovic et al. DEVELOPMENTAL NEUROSCIENCE
- Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome
- (2011) Zhong-Hua Liu et al. NEUROBIOLOGY OF DISEASE
- Executive dysfunction in young FMR1 premutation carriers: Forme fruste of FXTAS or new phenotype?
- (2011) E. Berry-Kravis et al. NEUROLOGY
- Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome
- (2011) Scott S. Hall et al. PSYCHONEUROENDOCRINOLOGY
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
- (2011) S. Jacquemont et al. Science Translational Medicine
- Open-label add-on treatment trial of minocycline in fragile X syndrome
- (2010) Carlo Paribello et al. BMC Neurology
- Open-label riluzole in fragile X syndrome
- (2010) Craig A. Erickson et al. BRAIN RESEARCH
- Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment
- (2010) Catherine H. Choi et al. BRAIN RESEARCH
- Co-occurring diagnoses amongFMR1premutation allele carriers
- (2010) JE Hunter et al. CLINICAL GENETICS
- NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout mice
- (2010) Brennan D. Eadie et al. HIPPOCAMPUS
- Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome
- (2010) Zhong-Hua Liu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Loss of the Fragile X Mental Retardation Protein Decouples Metabotropic Glutamate Receptor Dependent Priming of Long-Term Potentiation From Protein Synthesis
- (2010) Benjamin D. Auerbach et al. JOURNAL OF NEUROPHYSIOLOGY
- Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome
- (2010) C. Gross et al. JOURNAL OF NEUROSCIENCE
- Dysregulation of mTOR Signaling in Fragile X Syndrome
- (2010) A. Sharma et al. JOURNAL OF NEUROSCIENCE
- Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
- (2010) E. K. Osterweil et al. JOURNAL OF NEUROSCIENCE
- Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome
- (2010) J. L. Olmos-Serrano et al. JOURNAL OF NEUROSCIENCE
- Fragile X mice: Reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus
- (2010) Sung Hwan Yun et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Aripiprazole in autism spectrum disorders and fragile X syndrome
- (2010) Craig A. Erickson et al. Neurotherapeutics
- Cholinergic dysfunction in fragile X syndrome and potential intervention: A preliminary1H MRS study
- (2009) Shelli R. Kesler et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
- (2009) Christopher J. Yuskaitis et al. BIOCHEMICAL PHARMACOLOGY
- A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
- (2009) E Berry-Kravis et al. JOURNAL OF MEDICAL GENETICS
- NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats
- (2009) Hans H Wei et al. Journal of Neuroinflammation
- NNZ-2566, a Glypromate Analog, Improves Functional Recovery and Attenuates Apoptosis and Inflammation in a Rat Model of Penetrating Ballistic-Type Brain Injury
- (2009) Xi-Chun May Lu et al. JOURNAL OF NEUROTRAUMA
- The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
- (2009) M. C. Montana et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Acamprosate: Recent Findings and Future Research Directions
- (2008) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effects of Acamprosate on Neuronal Receptors and Ion Channels Expressed inXenopusOocytes
- (2008) Matthew T. Reilly et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- MosaicFMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: A case report and review of the literature
- (2008) Bradford Coffee et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Co-occurring conditions associated withFMR1gene variations: Findings from a national parent survey
- (2008) Donald B. Bailey et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome
- (2008) Ning Weng et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS)
- (2008) Charlotte D'Hulst et al. BRAIN RESEARCH
- The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
- (2008) Ilaria Napoli et al. CELL
- A Direct Role for FMRP in Activity-Dependent Dendritic mRNA Transport Links Filopodial-Spine Morphogenesis to Fragile X Syndrome
- (2008) Jason B. Dictenberg et al. DEVELOPMENTAL CELL
- Fragile X syndrome
- (2008) Kathryn B Garber et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
- (2008) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome
- (2008) H. Hu et al. JOURNAL OF NEUROSCIENCE
- Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field ofFmr1knockout mice
- (2008) Yair Pilpel et al. JOURNAL OF PHYSIOLOGY-LONDON
- Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila
- (2008) Shuang Chang et al. Nature Chemical Biology
- Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABAA-receptors
- (2008) K. Jahn et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Advances in the Treatment of Fragile X Syndrome
- (2008) R. J. Hagerman et al. PEDIATRICS
- Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome
- (2008) S. H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Primary ovarian insufficiency: a more accurate term for premature ovarian failure
- (2007) Corrine K. Welt CLINICAL ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now